Intelligence Platform
Patents
Browse 738 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9890126
Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)
granted patentUS 9890163
Inhibitors of protein kinases
granted patentUS 9877956
Antiviral compounds and methods of use thereof
granted patentUS 9879032
Pyridine compounds
granted patentUS 9861621
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted patentUS 9855249
Isoxazole compounds and methods for the treatment of cystic fibrosis
granted patentUS 9856238
1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
granted patentUS 9856260
Compounds useful for inhibiting metastasis from cancer and methods using same
granted patentUS 9856262
Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors
granted patentUS 9856264
Isoquinolinesulfonyl derivative as RHO kinase inhibitor
granted patentUS 9839624
Flavonoid compositions and methods of use
granted patentUS 9833406
Lubricant formulations
granted patentUS 9833471
Hypochlorous acid-based hand sanitizer
granted patentUS 9822117
Pyridoindolobenz[b,d]azepine derivatives and uses thereof
granted patentUS 9815825
Coumarin derivatives and methods of use in treating cystic fibrosis, chronic obstructive p
granted patentUS 9809604
DGAT1 inhibitor and preparation method and use thereof
granted patentUS 9790215
Pyridazinone compounds and methods for the treatment of cystic fibrosis
granted patentUS 9783578
Immunosuppression modulating compounds
granted patentUS 9783529
Pyridazinone compounds and methods for the treatment of cystic fibrosis
granted patentUS 9777024
Heteroaryl inhibitors of PDE4
granted patentUS 9776978
1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
granted patentUS 9771338
1,2,4-oxadiazole derivatives as immunomodulators
granted patentUS 9771327
Compounds and methods for the treatment of cystic fibrosis
granted patentUS 9758529
Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disor
granted